Engberding Niels, Wenger Nanette K
Department of Medicine, Division of Cardiology, National Jewish Health, Denver, Colorado, USA.
Emory Heart and Vascular Center, Atlanta, Georgia, USA.
F1000Res. 2017 Oct 2;6:1791. doi: 10.12688/f1000research.11064.1. eCollection 2017.
The clinical evidence for treatment of acute coronary syndrome (ACS) in the elderly is less robust than in patients younger than 75 years. The elderly have the highest incidence of cardiovascular disease and frequently present with ACS. This number can be expected to increase over time because society is aging. Older adults often sustain unfavorable outcomes from ACS because of atypical presentation and delay in recognition. In addition, elderly patients commonly do not receive optimal guideline-directed ACS treatment. Owing to their high baseline risk of ischemic complications, the elderly also fare worse even with optimal ACS treatment as they frequently have more complex coronary disease, more comorbidities, less cardiovascular reserve, and a higher risk of treatment complications. They are also subjected to a broader range of pharmacologic treatment. Treatment complications can be mitigated to some extent by meticulous dose adjustment of antithrombotic and adjunctive therapies. While careful transitions of care and appropriate utilization of post-discharge secondary preventive measures are important in ACS patients of all ages, the elderly are more vulnerable to system errors and thus deserve special attention from the clinician.
与75岁以下患者相比,老年急性冠状动脉综合征(ACS)患者的临床治疗证据不够充分。老年人心血管疾病发病率最高,且常表现为ACS。随着社会老龄化,这一数字预计还会增加。由于临床表现不典型且识别延迟,老年人常因ACS导致不良后果。此外,老年患者通常未接受最佳的指南指导的ACS治疗。由于缺血性并发症的基线风险较高,即使接受最佳的ACS治疗,老年人的情况也更糟,因为他们常患有更复杂的冠状动脉疾病、更多的合并症、心血管储备较少且治疗并发症风险较高。他们还需要接受更广泛的药物治疗。通过精心调整抗血栓和辅助治疗的剂量,可在一定程度上减轻治疗并发症。虽然在所有年龄段的ACS患者中,谨慎的护理过渡和出院后二级预防措施的适当使用都很重要,但老年人更容易出现系统错误,因此值得临床医生特别关注。